Skip to content

Clinical trials

Phase 2 Glioma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20071
20112
20141
20161
20172
20194
20201
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals2
Actuate Therapeutics Inc.1
Celgene1
Centre Oscar Lambret1
Eli Lilly and Company1
Fore Biotherapeutics1
Gustave Roussy, Cancer Campus, Grand Paris1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma19
Brain Neoplasms5
Central Nervous System Neoplasms5
Oligodendroglioma5
Glioblastoma4
Astrocytoma3
Gastrointestinal Stromal Tumors3
Neoplasms3
Biliary Tract Neoplasms2
Breast Neoplasms2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.